Andrew Komjathy

Chief Commercial Officer, Catabasis Pharmaceuticals.

Companies

Catabasis PharmaceuticalsChief Commercial Officer Sep 19, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Catabasis Pharmaceuticals CATB0 shares²Jan 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 23, 2026Returned to company 45 shares of Catabasis Pharmaceuticals²
Jan 23, 2026Returned to company 45 shares of Catabasis Pharmaceuticals²
Jan 23, 2026Returned to company 10 shares of Catabasis Pharmaceuticals²
Dec 28, 2021Gift 45 shares of Catabasis Pharmaceuticals³
Dec 28, 2021Gift 45 shares of Catabasis Pharmaceuticals³
Nov 19, 2021Bought 100 shares at $6.70 of Catabasis Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCatabasis Pharmaceuticals, Chief Commercial Officer
2
SEC EDGARCatabasis Pharmaceuticals shares after the filing of Jan 23, 2026
3
SEC EDGARForm 5 filed Feb 10, 2022
4
SEC EDGARForm 4 filed Nov 23, 2021